Novo Nordisk is seeking to replace the existing glucagon-like peptide-1 (GLP-1) receptor agonist (RA) with a second-generation drug, semaglutide, to fight diabetes and obesity in Korea.On Thursday, the Ministry of Food and Drug Safety authorized the use of Novo Nordisk’s Ozempic to treat adults with
LG Chem said that it has signed a local joint sales contract with Kyowa Kirin Korea for Nesp and Regpara, its chronic kidney disease (CKD) treatments.Under the accord, LG Chem will operate at the clinic and hospital level, while Kyowa Kirin Korea will operate at the general hospital level.LG Chem pl
Daewoong Pharmaceutical said it signed an agreement with UCI Therapeutics, a CAR-NK cell treatment developer, to conduct joint research on immune cell therapy on Tuesday.Under the agreement, the two companies will cooperate in developing immune cell therapy based on their cell therapy development an
Helixmith said it has signed a three-party memorandum of understanding with Cartexell and GI Cell for joint research on cell gene therapy products.The trilateral MOU will encourage cooperation between the three companies to identify candidate materials for cell gene therapy and cooperate in manufact
Labor union members of Sanofi Aventis Korea, the offshoot of the French-based multinational pharmaceutical company, have filed a lawsuit against the company's general manager and human resources head for failing to pay overtime allowances.The union filed a lawsuit on behalf of four of its members on
Pfizer Korea aims to strengthen its position in the local dermatology market with the launch of its first dermatology product Cibinqo (ingredient: abrocitinib), a treatment for moderate to severe atopic dermatitis, the company said.Cibinqo is a Janus kinase 1 (JAK1) inhibitor released in Korea on Ap
Transgene, Sillajen’s EU partner, published the result of using Pexa-Vec, an oncolytic virus therapy, as preoperative therapy for nine patients with either colorectal cancer liver metastases or metastatic melanoma scheduled for surgery.The company conducted the clinical trial from September 2015 to
Menarini Korea’s labor union said it struck a collective bargaining agreement with the company 18 months after sitting at the negotiating table.Union leaders and Menarini managers held a signing ceremony on Monday.The union and management agreed to improve the collective bargaining system and increa
Liveome, a subsidiary of Medytox, said that it successfully attracted 7 billion won ($5.6 million) Series A funding from Lindeman Asia Investment Group.Liveome is a microbiological research-based drug development company established in 2021 after licensing live biotherapeutic product (LBP) candidate
AbbVie released a high dose of Skyrizi (ingredient: risankizumab), an interleukin-23 (IL-23) inhibitor.On Friday, the Ministry of Food and Drug Safety authorized the use of Skyrizi Prefilled Syringe 150mg and Prefilled Pen 150mg to treat adults with moderate to severe plaque psoriasis.Skyrizi 150mg
Over the past two years, terms like virus, bacteria, vaccine, bio, and microbiome have become household words both here and abroad. So it seems timely for the nation to host an international industrial expo to turn these areas into new industries of the post-Covid-19 era.“The 2022 International Viru
SK Bioscience said that it has secured excellent phase 3 clinical results for GBP510, its Covid-19 vaccine.SK Bioscience conducted phase 3 clinical trials in 4,037 adults over 18 at 16 clinical institutions in Korea, including Korea University Guro Hospital, and five overseas countries -- Thailand,
Daewoong Pharmaceutical said it completed a phase 3 clinical trial of Nabota, a botulinum toxin treatment, aimed to win indication for benign masseter hypertrophy, and applied for a marketing license of Nabota.On Thursday, the company said it applied to the Ministry of Food and Drug Safety for addin
Samsung Biologics said Wednesday that it officially incorporated Samsung Bioepis as a wholly-owned subsidiary.The announcement follows Samsung Biologics completing its first payment of the $1 billion to Biogen regarding the acquisition of Samsung Bioepis.Biogen had owned 50 percent minus one share i
SK Bioscience is likely to name its experimental Covid-19 vaccine (GBP510) “SKY Covione,” a patent information service site showed.The product's name draws particular attention because it will become if authorized by the Ministry of Food and Drug Safety, the nation’s 35th novel drug and the first ho
GI Innovation said Thursday that it has submitted a preliminary application to be listed on the secondary Kosdaq market.The lead organizers are NH Investment & Securities and Hana Financial Investment, and the associated listed organizer is Samsung Securities.The company stressed that the applicatio
SK Chemicals said it would start joint research on innovative new drugs with Oncobix, a synthetic new drug developer.Under the accord, Oncobix will derive new drug candidates and conduct synthesis research based on TOPFOMICS, its drug development platform. In addition, SK Chemicals will conduct gene
LG Chem said its Chinese partner company Transthera Bioscience obtained the Chinese National Medical Products Administration (NMPA)’s authorization to conduct a phase 2 trial of LC510255, an autoimmune disease treatment in patients with atopic dermatitis.In April last year, LG Chem signed a licensin
Boryung Pharmaceutical said it would open the first Care In Space (CIS) Challenge, a global competition event to find technologies and solutions for human health in space.Boryung leads the CIS challenge in collaboration with Axiom Space, an American human spaceflight services provider, and Starbust,
GC Cell said that it acquired a 100 percent stake in BioCentriq, an American cell and gene therapy contract development and manufacturing organization (CDMO) company, together with GC.The acquisition follows the merger completion of GC Cell and GC Labcell last November.BioCentriq, a subsidiary of th